Hanson, Q. M., Wilson, K. M., Shen, M., Itkin, Z., Eastman, R. T., Shinn, P., & Hall, M. D. (2020). Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay. bioRxiv.
Chicago-tyylinen lähdeviittausHanson, Quinlin M., Kelli M. Wilson, Min Shen, Zina Itkin, Richard T. Eastman, Paul Shinn, ja Matthew D. Hall. "Targeting ACE2-RBD Interaction As a Platform for COVID19 Therapeutics: Development and Drug Repurposing Screen of an AlphaLISA Proximity Assay." BioRxiv 2020.
MLA-viiteHanson, Quinlin M., et al. "Targeting ACE2-RBD Interaction As a Platform for COVID19 Therapeutics: Development and Drug Repurposing Screen of an AlphaLISA Proximity Assay." BioRxiv 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.